Alliances
Google and Sanofi are partnering to set up a new virtual innovation lab with a focus on data technologies and digital health. The goal is to change how Sanofi develops new drugs.
“Our alliance with Sanofi Genzyme has been foundational for Voyager as we optimized the development of capsids, transgenes and gene therapy delivery,” stated Andre Turenne, president and chief executive officer of Voyager. “We look forward to this new stage of the relationship and to advancing our programs and research efforts for patients with severe neurological diseases.”
Bioz, Inc., a Silicon Valley AI data company, is proud to announce a new partnership with the world leader in the discovery and production of enzymes for molecular biology applications: New England Biolabs®.
Virtue® SEB is expected to become a flagship therapeutic product for Terumo and will strengthen its broad US and global portfolio of interventional solutions
The pilot program aims to develop an electronic system to identify and trace certain prescription drugs as they are distributed within the United States.
The collaboration with China-Singapore Guangzhou Knowledge City will focus on the most prevalent cancers in China.
AbCellera will use its technology to look for ultra-rare antibodies with specific properties defined by Gilead.
Fuels development of Synlogic’s growing pipeline of novel living medicines with technology access and $80.0 million equity investment at a premium
Since the opening of Alexandria LaunchLabs at the Alexandria Center for Life Science – NYC in June 2017, its member companies have collectively raised more than $300 million in financing, with two of its companies completing IPOs
“We are honored to join with The Bill & Melinda Gates Foundation to fight tuberculosis, one of the world’s most deadly infectious diseases,” stated Werner Lanthaler, Evotec’s chief executive officer.
PRESS RELEASES